# Efficacy and Safety of Sirolimus in COVID-19 Infection

> **NCT04461340** · PHASE2 · UNKNOWN · sponsor: **Alexandria University** · enrollment: 40 (estimated)

## Conditions studied

- COVID 19

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT04461340
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-15
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04461340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04461340, "Efficacy and Safety of Sirolimus in COVID-19 Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04461340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*